ArticleCancers2021

Thrombospondin-2 and LDH Are Putative Predictive Biomarkers for Treatment with Everolimus in Second-Line Metastatic Clear Cell Renal Cell Carcinoma (MARC-2 Study).

Philip Zeuschner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.